Log In
person
Cara Therapeutics Inc
CARA
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pharma Drug Design |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
18.78M | 89.56% |
| Pharma Drug Design |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
2.02M | 9.65% |
| Pharma Drug Design |
Active Pharma Ingredients (outsourced)
These companies develop Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs, and use contract manufacturers to actually produce the APIs.
|
0.17M | 0.79% |
| keyboard_arrow_down |
Pharma Drug Design
Branded Pharmaceuticals (outsourced)
|
18.78M | 89.56% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Pharma Drug Design
Pharmaceutical Patent Licensing
|
2.02M | 9.65% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Pharma Drug Design
Active Pharma Ingredients (outsourced)
|
0.17M | 0.79% |
| keyboard_arrow_right |
These companies develop Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs, and use contract manufacturers to actually produce the APIs.
|
||